About Liberation Labs
Liberation Labs is a company based in New York (United States) founded in 2022 by Etan Bendheim and Mark Warner. Liberation Labs has raised $107.61 million across 8 funding rounds from investors including NEOM, Agronomics and Meach Cove Capital. Liberation Labs offers products and services including Precision Fermentation Services and Biomanufacturing Hub. Liberation Labs operates in a competitive market with competitors including NJ Bio, Kinaxo Biotechnologies, Shantani Proteome Analytics, Scala Biodesign and Seranova, among others.
- Headquarter New York, United States
- Founders Etan Bendheim, Mark Warner
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Liberation Labs Holdings Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$107.61 M (USD)
in 8 rounds
-
Latest Funding Round
$51.98 M (USD), Series C
Jan 28, 2025
-
Investors
NEOM
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Liberation Labs
Liberation Labs offers a comprehensive portfolio of products and services, including Precision Fermentation Services and Biomanufacturing Hub.
Offers design, build, and operate services for sustainable bioproducts
Provides commercial-scale fermentation for alternative proteins and materials
People of Liberation Labs
Unlock access to complete
Funding Insights of Liberation Labs
Liberation Labs has successfully raised a total of $107.61M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $51.98 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Liberation Labs
Liberation Labs has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include NEOM, Agronomics and Meach Cove Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Meach Cove Capital is focused on investing in food and agriculture innovations.
|
Locked | Locked | Locked | |
|
Investments are directed toward cellular agriculture and biomanufacturing firms.
|
Locked | Locked | Locked | |
|
Venture investments in foodtech sectors are managed by Siddhi Capital.
|
Locked | Locked | Locked |
Investor details for Liberation Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Liberation Labs
Investment portfolio details for Liberation Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Liberation Labs
Detailed financials for Liberation Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Liberation Labs Comparisons
Peer comparison for Liberation Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Liberation Labs
Liberation Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NJ Bio, Kinaxo Biotechnologies, Shantani Proteome Analytics, Scala Biodesign and Seranova, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical development services are provided for biotechnology applications.
|
|
| Locked | Locked | Locked |
Chemical proteomics for cellular target profiling and drug discovery services
|
|
| Locked | Locked | Locked |
Drug discovery services are delivered via chemical-proteomics technologies.
|
|
| Locked | Locked | Locked |
Computational protein design solutions are delivered at scale.
|
|
| Locked | Locked | Locked |
CRO offering chemical proteomics services for preclinical development of drug
|
Detailed competitors of Liberation Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Liberation Labs
Complete news archive for Liberation Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Liberation Labs
Liberation Labs was founded in 2022.
Liberation Labs is headquartered in New York, United States. It is registered at New York, New York, United States.
Mark Warner is the current CEO of Liberation Labs. They have also founded this company.
Liberation Labs is a funded company, having raised a total of $107.61M across 8 funding rounds to date.
Liberation Labs was established in 2022 in New York, United States, as a contract research organization (CRO) in the biotechnology sector. Fermentation-based products are developed, manufactured, and commercialized through its specialized services. Operations focus on scalable production processes for clients, supporting transitions from research to market deployment. End-to-end assistance is provided in precision fermentation, with facilities geared toward industrial applications in sustainable biomanufacturing.
Liberation Labs's top competitors include NJ Bio, Shantani Proteome Analytics and Kinaxo Biotechnologies.
Liberation Labs offers Precision Fermentation Services and Biomanufacturing Hub.
Liberation Labs has 12 investors. Key investors include NEOM, Agronomics, Meach Cove Capital, Siddhi Capital, and Fabul'E Sacs.